IL4 and neoplasm: According to existing reports, increased Th2 marker levels accelerate the secretion of interleukin(IL)-10 and IL-4 and inhibit cellular immune function, and the GATA3/T-bet(G/T) ratio of tumor-infiltrating lymphoid cells is an independent negative predictive marker for survival (54, 55).